本文選題：腹腔鏡 + 膀胱癌��； 參考：《重慶醫(yī)學(xué)》2017年01期

【摘要】：目的探討單中心腹腔鏡下根治性膀胱切除術(shù)治療膀胱癌安全性及腫瘤控制的效果。方法選擇2009年9月至2015年9月本中心所行腹腔鏡下根治性膀胱切除、尿流改道術(shù)患者53例,收集臨床病理資料,并對(duì)術(shù)后并發(fā)癥及生存情況進(jìn)行隨訪,運(yùn)用Kaplan-Meier法分析生存數(shù)據(jù),得出術(shù)后3年的生存率。結(jié)果所有手術(shù)均成功在腹腔鏡下完成,平均手術(shù)時(shí)間(417±111)min,平均出血量(491±355)mL,輸血率34.0%,術(shù)后平均住院時(shí)間為(21.1±9.6)d。近期并發(fā)癥發(fā)生率37.7%(20/53),遠(yuǎn)期并發(fā)癥發(fā)生率22.6%(12/53)。本組病理多為尿路上皮癌(88.7%),其中高級(jí)別腫瘤占57.1%,浸潤(rùn)性膀胱癌(T2期及以上)占77.4%。平均隨訪時(shí)間(24±19)個(gè)月,截至2015年12月,29例(54.7%)無(wú)瘤存活,3年總體生存率為57.0%,無(wú)復(fù)發(fā)生存率為72.0%,腫瘤特異性生存率為74.0%,亞組分析顯示70歲及以下比70歲以上者總體生存率高,非肌層浸潤(rùn)性比肌層浸潤(rùn)性膀胱癌總體生存率高。結(jié)論腹腔鏡下根治性膀胱切除術(shù)安全有效,中期隨訪結(jié)果顯示對(duì)腫瘤的控制滿意,與開(kāi)放性手術(shù)具有可比性。
[Abstract]:Objective to evaluate the safety and tumor control of single-center laparoscopic radical cystectomy for bladder cancer. Methods from September 2009 to September 2015, 53 patients underwent laparoscopic radical cystectomy and urinary diversion were selected. The clinical and pathological data were collected, and the postoperative complications and survival conditions were followed up. Survival data were analyzed by Kaplan-Meier method. The 3-year survival rate was obtained. Results all the operations were successfully performed under laparoscopy. The mean operation time was 417 鹵111 minutes, the mean blood loss was 491 鹵355mL, the blood transfusion rate was 34.0 and the average hospital stay was 21.1 鹵9.6 days. The incidence of short term complications was 37. 7% 20 / 53 and 22. 6% / 53%. Most of the cases were urethral epithelial carcinoma (88.7%), including 57.1% of high grade tumors and 77.4% of invasive bladder carcinoma at T2 stage and above. The mean follow-up time was 24 鹵19 months. As of December 2015, 29 patients (54.74.7a) survived without tumor. The overall 3-year survival rate was 57.0, the recurrence free survival rate was 72.0, and the tumor-specific survival rate was 74.0. The subgroup analysis showed that the overall survival rate of patients aged 70 years and below was higher than that of those over 70 years old. The overall survival rate of non-myometrial invasive bladder cancer was higher than that of myometrial invasive bladder cancer. Conclusion Laparoscopic radical cystectomy is safe and effective. The results of mid-term follow-up show that the control of tumor is satisfactory and comparable with open operation.
【作者單位】： 四川省醫(yī)學(xué)科學(xué)院/四川省人民醫(yī)院泌尿外科;
【分類號(hào)】：R737.14

【相似文獻(xiàn)】

相關(guān)期刊論文 前7條

1 Box B.;Lindsey I.;Wheeler J.M. ;陳云茹;;直腸癌新的輔助治療可改善非貧血患者的腫瘤應(yīng)答率、降低局部復(fù)發(fā)率和提高總體生存率[J];世界核心醫(yī)學(xué)期刊文摘(胃腸病學(xué)分冊(cè));2005年11期

2 薛鈺婷;李曉明;;急性髓細(xì)胞白血病的治療進(jìn)展[J];西南軍醫(yī);2011年04期

3 陸洋;瞿利帥;錢海鑫;;乙型肝炎相關(guān)性肝癌根治術(shù)后IFN-α治療對(duì)于腫瘤復(fù)發(fā)和生存率的影響[J];中國(guó)腫瘤生物治療雜志;2014年02期

4 王霞;高獻(xiàn)書(shū);;食管癌放射治療設(shè)定照射野范圍的分析研究[J];中華腫瘤防治雜志;2006年05期

5 郭立偉;黃自明;王蓉;薛明興;魏剛;;多西紫杉醇對(duì)可切除的淋巴結(jié)陽(yáng)性乳腺癌的療效分析[J];現(xiàn)代腫瘤醫(yī)學(xué);2014年08期

6 黃林;郭衛(wèi);楊榮利;燕太強(qiáng);尉然;;16例脛骨轉(zhuǎn)移癌的外科治療[J];北京大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2013年05期

7 ;[J];;年期

相關(guān)重要報(bào)紙文章 前1條

1 阿勝;兩種治療淋巴結(jié)陽(yáng)性乳腺癌的化療方案療效比較[N];醫(yī)藥經(jīng)濟(jì)報(bào);2005年

相關(guān)博士學(xué)位論文 前1條

1 陳鳴;喉癌預(yù)后影響因素的分析[D];浙江大學(xué);2015年

相關(guān)碩士學(xué)位論文 前2條

1 胡玉龍;十二指腸間質(zhì)瘤預(yù)后多中心回顧性分析(山東省胃腸外科研究協(xié)作組1201研究)[D];青島大學(xué);2015年

2 宋曉明;前列腺癌篩查及治療的臨床研究進(jìn)展[D];蚌埠醫(yī)學(xué)院;2016年

，

本文編號(hào)：1935906